Literature DB >> 9270377

Antihyperglycemic effects of paeoniflorin and 8-debenzoylpaeoniflorin, glucosides from the root of Paeonia lactiflora.

F L Hsu1, C W Lai, J T Cheng.   

Abstract

Paeoniflorin and 8-debenzoylpaeoniflorin were isolated from the dried root of Paeonia lactiflora Pall. (Ranunculaceae). They produced a significant blood sugar lowering effect in streptozotocin-treated rats and had a maximum effect at 25 min after treatment. This hypoglycemic action was also observed in normoglycemic rats only at 1 mg/kg. The antihyperglycemic activity of 8-debenzoylpaeoniflorin seems lower than that of paeoniflorin. Plasma insulin was not changed in paeoniflorin-treated normoglycemic rats indicating an insulin-independent action. Also, this glucoside reduced the elevation of blood sugar in glucose challenged rats. Increase of glucose utilization by paeoniflorin can thus be considered. There are no previous data showing the hypoglycemic activity of paeoniflorin and/or 8-debenzoylpaeoniflorin in rats.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9270377     DOI: 10.1055/s-2006-957692

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  25 in total

1.  Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats.

Authors:  I M Liu; F L Hsu; C F Chen; J T Cheng
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Paeoniflorin, a novel heat shock protein-inducing compound.

Authors:  Dai Yan; Kiyoto Saito; Yuri Ohmi; Noriyo Fujie; Kenzo Ohtsuka
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

3.  Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor.

Authors:  Hua-Qing Liu; Wei-Yu Zhang; Xue-Ting Luo; Yang Ye; Xing-Zu Zhu
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

4.  Paeoniflorin abrogates DSS-induced colitis via a TLR4-dependent pathway.

Authors:  Jingjing Zhang; Wei Dou; Eryun Zhang; Aning Sun; Lili Ding; Xiaohui Wei; Guixin Chou; Sridhar Mani; Zhengtao Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-14       Impact factor: 4.052

5.  Paeoniflorin prevents diabetic nephropathy in rats.

Authors:  Jianfang Fu; Yuan Li; Li Wang; Bin Gao; Nanyan Zhang; Qiuhe Ji
Journal:  Comp Med       Date:  2009-12       Impact factor: 0.982

6.  A 12-week, randomized, double-blind, placebo-controlled study assessing the efficacy of EGHB010, a standardized extract of Paeoniae radix and Glycyrrhizae radix, in patients with early age-related macular degeneration.

Authors:  Joo Young Kim; Mirinae Kim; Rae Young Kim; Woo Kyung Park; Young-Hoon Park
Journal:  Ann Transl Med       Date:  2021-04

7.  The traditional Japanese formula keishibukuryogan inhibits the production of inflammatory cytokines by dermal endothelial cells.

Authors:  Yoko Yoshihisa; Megumi Furuichi; Mati Ur Rehman; Chieko Ueda; Teruhiko Makino; Tadamichi Shimizu
Journal:  Mediators Inflamm       Date:  2010-12-28       Impact factor: 4.711

8.  Potential mechanisms of an antiadenomyosis chinese herbal formula shaoyao-gancao decoction in primary cell culture model.

Authors:  Yong-Ge Guan; Jin-Bin Liao; Kun-Yin Li; Yu-Cui Li; Yang Song; Jing Ling; Zi-Ren Su
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-10       Impact factor: 2.629

9.  Paeoniflorin reduced BLP-induced inflammatory response by inhibiting the NF-κB signal transduction in pathway THP-1 cells.

Authors:  Qian Zhang; Jing Zhou; Min Huang; Liqing Bi; Suming Zhou
Journal:  Cent Eur J Immunol       Date:  2014-12-15       Impact factor: 2.085

10.  Preliminary in vitro and in vivo evaluation of antidiabetic activity of Ducrosia anethifolia Boiss. and its linear furanocoumarins.

Authors:  Nagwa M M Shalaby; Howaida I Abd-Alla; Hanan F Aly; Marzougah A Albalawy; Kamel H Shaker; Jalloul Bouajila
Journal:  Biomed Res Int       Date:  2014-03-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.